Literature DB >> 20968266

Insomnia is the most commonly reported symptom and predicts other symptoms of post-traumatic stress disorder in U.S. service members returning from military deployments.

Robert N McLay1, Warren P Klam, Stacy L Volkert.   

Abstract

This study retrospectively reviewed records from current members of the U.S. military who had completed the PTSD Checklist (PCL) at 0 and 3-months after returning from deployments. Insomnia was the most commonly reported symptom of PTSD on the PCL and had the highest average severity scores. At initial screen, 41% of those who had been to Iraq or Afghanistan reported sleep problems. Those who had initially reported any insomnia had significantly higher overall scores for PTSD severity at follow-up than did service members without such a complaint. These results show that insomnia is a particularly frequent, severe, and persistent complaint in service members returning from deployment. Such complaints merit particular attention in relation to the possibility of PTSD.

Entities:  

Mesh:

Year:  2010        PMID: 20968266     DOI: 10.7205/milmed-d-10-00193

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  67 in total

1.  Prescription Patterns of Sedative Hypnotic Medications in the Military Health System.

Authors:  Rosenie Thelus Jean; Yingxin Hou; James Masterson; Adrian Kress; Vincent Mysliwiec
Journal:  J Clin Sleep Med       Date:  2019-06-15       Impact factor: 4.062

2.  Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances in US Military Veterans.

Authors:  Anne Germain; Robin Richardson; Douglas E Moul; Oommen Mammen; Gretchen Haas; Steven D Forman; Noelle Rode; Amy Begley; Eric A Nofzinger
Journal:  J Psychosom Res       Date:  2011-12-20       Impact factor: 3.006

3.  Pre-deployment insomnia is associated with post-deployment post-traumatic stress disorder and suicidal ideation in US Army soldiers.

Authors:  Hohui E Wang; Laura Campbell-Sills; Ronald C Kessler; Xiaoying Sun; Steven G Heeringa; Matthew K Nock; Robert J Ursano; Sonia Jain; Murray B Stein
Journal:  Sleep       Date:  2019-02-01       Impact factor: 5.849

Review 4.  Prevalence of, risk factors for, and consequences of posttraumatic stress disorder and other mental health problems in military populations deployed to Iraq and Afghanistan.

Authors:  Rajeev Ramchand; Rena Rudavsky; Sean Grant; Terri Tanielian; Lisa Jaycox
Journal:  Curr Psychiatry Rep       Date:  2015-05       Impact factor: 5.285

5.  Sleep in the Military: Promoting Healthy Sleep Among U.S. Servicemembers.

Authors:  Wendy M Troxel; Regina A Shih; Eric R Pedersen; Lily Geyer; Michael P Fisher; Beth Ann Griffin; Ann C Haas; Jeremy Kurz; Paul S Steinberg
Journal:  Rand Health Q       Date:  2015-11-30

Review 6.  Patterns of Zolpidem Use in Male and Female Veterans Following Revised FDA Dosing Guidelines.

Authors:  Sabra S Inslicht; Thomas C Neylan
Journal:  J Clin Sleep Med       Date:  2018-07-15       Impact factor: 4.062

7.  Nightmares and Insomnia in the US National Guard: Mental and Physical Health Correlates.

Authors:  Kristi E Pruiksma; Danica C Slavish; Daniel J Taylor; Jessica R Dietch; Hannah Tyler; Megan Dolan; AnnaBelle O Bryan; Craig J Bryan
Journal:  Int J Behav Med       Date:  2021-04

8.  Sleep variability in military-related PTSD: a comparison to primary insomnia and healthy controls.

Authors:  Laura D Straus; Sean P A Drummond; Carla M Nappi; Melissa M Jenkins; Sonya B Norman
Journal:  J Trauma Stress       Date:  2015-01-28

9.  Sleep disturbances after deployment: National Guard soldiers' experiences and strategies.

Authors:  Martha L Lincoln; Roland S Moore; Genevieve M Ames
Journal:  Sleep Health       Date:  2018-06-22

10.  The relationship between military occupation and diagnosed insomnia following combat deployment.

Authors:  Andrew J MacGregor; Rachel R Markwald; Amber L Dougherty; Gilbert Seda
Journal:  J Clin Sleep Med       Date:  2020-07-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.